
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics
Cody L. Nesvick, Lucie Lafay‐Cousin, Aditya Raghunathan, et al.
Journal of Neuro-Oncology (2020) Vol. 150, Iss. 1, pp. 47-56
Open Access | Times Cited: 46
Cody L. Nesvick, Lucie Lafay‐Cousin, Aditya Raghunathan, et al.
Journal of Neuro-Oncology (2020) Vol. 150, Iss. 1, pp. 47-56
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target
Sophie M. Navickas, Katherine A. Giles, Kate H. Brettingham‐Moore, et al.
Oncogene (2023) Vol. 42, Iss. 31, pp. 2363-2373
Open Access | Times Cited: 21
Sophie M. Navickas, Katherine A. Giles, Kate H. Brettingham‐Moore, et al.
Oncogene (2023) Vol. 42, Iss. 31, pp. 2363-2373
Open Access | Times Cited: 21
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
Elizabeth Alva, Jeffrey Rubens, Susan Chi, et al.
Neoplasia (2023) Vol. 37, pp. 100880-100880
Open Access | Times Cited: 19
Elizabeth Alva, Jeffrey Rubens, Susan Chi, et al.
Neoplasia (2023) Vol. 37, pp. 100880-100880
Open Access | Times Cited: 19
Development of a Nomogram and Risk Grouping System for Predicting 1-Year Overall Survival of Patients With Atypical Teratoid/Rhabdoid Tumors
Kang Xu, Yabing Zhou, Fangjie Shen, et al.
Journal of Child Neurology (2025)
Closed Access
Kang Xu, Yabing Zhou, Fangjie Shen, et al.
Journal of Child Neurology (2025)
Closed Access
Novel SMARCA4 Variant in an Infant With Atypical Teratoid Rhabdoid Tumor
Shria K. Haldipurkar, Sudarshawn Damodharan, Pamela Rathbun, et al.
Journal of Pediatric Hematology/Oncology (2025)
Closed Access
Shria K. Haldipurkar, Sudarshawn Damodharan, Pamela Rathbun, et al.
Journal of Pediatric Hematology/Oncology (2025)
Closed Access
Navigating the complexity of atypical teratoid/rhabdoid tumor (ATRT) in pediatric neuro-oncology: Insights from clinical spectrum to therapeutic challenges
Ali Msheik, Mohamad Yazbeck, Abdulla Illeyan, et al.
International Journal of Surgery Case Reports (2025) Vol. 131, pp. 111354-111354
Open Access
Ali Msheik, Mohamad Yazbeck, Abdulla Illeyan, et al.
International Journal of Surgery Case Reports (2025) Vol. 131, pp. 111354-111354
Open Access
Pediatric Neuro-Oncology
Fatema Malbari
Neurologic Clinics (2021) Vol. 39, Iss. 3, pp. 829-845
Closed Access | Times Cited: 24
Fatema Malbari
Neurologic Clinics (2021) Vol. 39, Iss. 3, pp. 829-845
Closed Access | Times Cited: 24
Posterior fossa tumors in children: An update and new concepts
Juan Pablo Mengide, María Florencia Berros, Mariana Estefanía Turza, et al.
Surgical Neurology International (2023) Vol. 14, pp. 114-114
Open Access | Times Cited: 10
Juan Pablo Mengide, María Florencia Berros, Mariana Estefanía Turza, et al.
Surgical Neurology International (2023) Vol. 14, pp. 114-114
Open Access | Times Cited: 10
Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors
Klára Vejmělková, Petra Pokorná, Kristýna Nosková, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Klára Vejmělková, Petra Pokorná, Kristýna Nosková, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
The evolution of pleomorphic xanthoastrocytoma: from genesis to molecular alterations and mimics
Swati Mahajan, Iman Dandapath, Ajay Garg, et al.
Laboratory Investigation (2022) Vol. 102, Iss. 7, pp. 670-681
Open Access | Times Cited: 13
Swati Mahajan, Iman Dandapath, Ajay Garg, et al.
Laboratory Investigation (2022) Vol. 102, Iss. 7, pp. 670-681
Open Access | Times Cited: 13
Current Molecular and Clinical Landscape of ATRT – The Link to Future Therapies
Katharina Gastberger, Victoria E. Fincke, Marlena Mucha, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 1369-1393
Open Access | Times Cited: 7
Katharina Gastberger, Victoria E. Fincke, Marlena Mucha, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 1369-1393
Open Access | Times Cited: 7
Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor
Le Hien Giang, Kuo-Sheng Wu, Wei-Chung Allen Lee, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 7
Le Hien Giang, Kuo-Sheng Wu, Wei-Chung Allen Lee, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 7
Atypical teratoid rhabdoid tumor in a lower middle‑income country: Challenges to cure
Ahmed Elhemaly, Marwa Samir, Hala Taha, et al.
Oncology Letters (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 2
Ahmed Elhemaly, Marwa Samir, Hala Taha, et al.
Oncology Letters (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 2
Molecular targeted therapies for pediatric atypical teratoid/rhabdoid tumors
Chang Zhang, Hao Li
Pediatric Investigation (2022) Vol. 6, Iss. 2, pp. 111-122
Open Access | Times Cited: 10
Chang Zhang, Hao Li
Pediatric Investigation (2022) Vol. 6, Iss. 2, pp. 111-122
Open Access | Times Cited: 10
MiRNAs in early brain development and pediatric cancer
Anna Prieto‐Colomina, Virginia Fernández, Kaviya Chinnappa, et al.
BioEssays (2021) Vol. 43, Iss. 7
Closed Access | Times Cited: 14
Anna Prieto‐Colomina, Virginia Fernández, Kaviya Chinnappa, et al.
BioEssays (2021) Vol. 43, Iss. 7
Closed Access | Times Cited: 14
A Carboxy-terminal Smarcb1 Point Mutation Induces Hydrocephalus Formation and Affects AP-1 and Neuronal Signalling Pathways in Mice
Aliska K. Brugmans, Carolin Walter, Natalia Moreno, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 7, pp. 3511-3526
Open Access | Times Cited: 5
Aliska K. Brugmans, Carolin Walter, Natalia Moreno, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 7, pp. 3511-3526
Open Access | Times Cited: 5
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors
Sarah Leary, Arzu Onar‐Thomas, Jason Fangusaro, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. S6
Open Access | Times Cited: 4
Sarah Leary, Arzu Onar‐Thomas, Jason Fangusaro, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. S6
Open Access | Times Cited: 4
Feeder-free differentiation of human iPSCs into natural killer cells with cytotoxic potential against malignant brain rhabdoid tumor cells
Sonia Kiran, Yu Xue, Drishty B. Sarker, et al.
Bioactive Materials (2024) Vol. 36, pp. 301-316
Open Access | Times Cited: 1
Sonia Kiran, Yu Xue, Drishty B. Sarker, et al.
Bioactive Materials (2024) Vol. 36, pp. 301-316
Open Access | Times Cited: 1
RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor
Le Hien Giang, Kuo-Sheng Wu, Wei-Chung Allen Lee, et al.
Neoplasia (2024) Vol. 58, pp. 101075-101075
Closed Access | Times Cited: 1
Le Hien Giang, Kuo-Sheng Wu, Wei-Chung Allen Lee, et al.
Neoplasia (2024) Vol. 58, pp. 101075-101075
Closed Access | Times Cited: 1
Absence of SMARCB1 in rhabdoid tumor cells increases sensitivity to translation inhibition and alters translation efficiency of specific mRNAs
L.T. Nguyen, Anastasia E. Hains, Mohammad Ovais Aziz-Zanjani, et al.
Journal of Biological Chemistry (2024), pp. 107988-107988
Open Access | Times Cited: 1
L.T. Nguyen, Anastasia E. Hains, Mohammad Ovais Aziz-Zanjani, et al.
Journal of Biological Chemistry (2024), pp. 107988-107988
Open Access | Times Cited: 1
Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers
Aleena Arakaki, Frank Szulzewsky, Mark R. Gilbert, et al.
Neuro-Oncology (2021) Vol. 23, Iss. Supplement_5, pp. S4-S15
Open Access | Times Cited: 10
Aleena Arakaki, Frank Szulzewsky, Mark R. Gilbert, et al.
Neuro-Oncology (2021) Vol. 23, Iss. Supplement_5, pp. S4-S15
Open Access | Times Cited: 10
Prolonged remission achieved with maintenance intraventricular chemotherapy in young patient with recurrent atypical teratoid rhabdoid tumor
Shelby Mestnik, Saul Wilson, Annie Huang, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 6
Closed Access | Times Cited: 3
Shelby Mestnik, Saul Wilson, Annie Huang, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 6
Closed Access | Times Cited: 3
A chromatin remodelling SWI/SNF subunit, Snr1, regulates neural stem cell determination and differentiation
Sophie E. Keegan, Julie Haskins, Andrew Simmonds, et al.
Development (2023) Vol. 150, Iss. 13
Open Access | Times Cited: 3
Sophie E. Keegan, Julie Haskins, Andrew Simmonds, et al.
Development (2023) Vol. 150, Iss. 13
Open Access | Times Cited: 3
Pediatric Posterior Fossa ATRT: A Case Report, New Treatment Strategies and Perspectives
Luca Paun, Alexandre Lavé, Gianpaolo Jannelli, et al.
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 712-712
Open Access | Times Cited: 2
Luca Paun, Alexandre Lavé, Gianpaolo Jannelli, et al.
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 712-712
Open Access | Times Cited: 2
Clinical diagnostic and radiographic features of primary spinal atypical teratoid rhabdoid tumor in a pediatric patient: A case report and review of the literature
Hashim Syed, Nahom Teferi, Alec Hanson, et al.
Journal of Central Nervous System Disease (2023) Vol. 15
Open Access | Times Cited: 2
Hashim Syed, Nahom Teferi, Alec Hanson, et al.
Journal of Central Nervous System Disease (2023) Vol. 15
Open Access | Times Cited: 2
Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT)
Kaitlyn Howden, Patrick J. McDonald, Colin Kazina, et al.
Neuro-Oncology Advances (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 4
Kaitlyn Howden, Patrick J. McDonald, Colin Kazina, et al.
Neuro-Oncology Advances (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 4